Table 1.

Baseline characteristics and health of the study participants (n = 323). Group A: patients with PsA. Group B: patients with arthritis and no psoriatic—any type of arthrosis—any type of dermatitis. Group C: healthy controls.

CharacteristicsGroup A, n = 209Group B, n = 71Group C, n = 43
Sociodemographic features
  Age, yrs*, mean (SD)48.7 (11.8)46.5 (15.2)42 (8.2)
  Female*, n (%)89 (42.6)43 (75.7)32 (74.4)
  Educational level*, n (%)
    No education6 (2.9)3 (4.3)0
    Primary education94 (45)34 (48.6)7 (16.4)
    Secondary education72 (34.3)13 (18.6)12 (27.9)
    University studies37 (17.7)20 (28.6)24 (55.8)
    Total209 (100)70 (100)43 (100)
  Employment status*, n (%)
    Working105 (50.5)31 (44.9)40 (93)
    Unemployed16 (7.6)5 (7.3)0
    Student3 (1.4)3 (4.3)0
    Retired46 (22.1)11 (15.9)0
    Housekeeper26 (12.5)16 (23.2)3 (7)
    Other12 (5.8)3 (4.3)0
    Total208 (100)69 (100)43 (100)
Health assessments
  EQ-5D VAS*, mean (SD)
    VAS (0–100)65.4 (22.1)65.1 (26.4)91.4 (14.1)
  EQ-5D descriptive system*, %
    Mobility problems44.326.92.5
    Self-care problems28.6270
    Daily activities problems47.819.10
    Pain/discomfort68.656.54.9
    Anxiety/depression5039.10
  Perceived health state*, %
    Good/very good39.145.597.1
  VITACORA-19*, mean (SD)
    Global score56.24 (24.8)69.23 (24.8)93.7 (9.1)
Clinical features
  Time from diagnosis, yrs, mean (SD)8 (7.5)8 (7.7)
  Psoriasis/other dermatitis diagnosis, n (%)203 (98.5)40 (56.3)
  Comorbidities, n (%)96 (45.9)30 (43.2)
  BSA, % (SD)22.4 (28.1)
  BASDAI, 0–10, mean (SD)2.2 (6.3)
  DAS28, 2–10, mean (SD)2.7 (1.5)
  • * p < 0.001.

  • Range from 0 (worst health status) to 100 (best health status).

  • Global score range from 0 (worst health-related quality of life) to 100 (best health-related quality of life). Statistical significant differences between study groups after adjusting by sociodemographic differences. PsA: psoriatic arthritis; EQ-5D: EuroQol questionnaire 5-Dimensional; VAS: visual analog scale; VITACORA-19: PsA quality of life questionnaire; BSA: body surface area; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; DAS28: 28-joint Disease Activity Score.